InnovaQor, Inc. VMCS OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

10/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

InnovaQor, Inc. (VMCS) generated $0.00 in operating cash flow for quarter ending 2023-09-30. After capital expenditures of $0.00, free cash flow was $0.00.

Free cash flow margin was 0% of revenue.

Criteria supported by this page:

HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
MOAT (0/100, Fail) — limited free cash flow weakens the competitive position

Overall SharesGrow Score: 9/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

10/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

0/100

Proven by this page

GROWTH

40/100

→ Income

✗

INCOME

10/100

→ Income

InnovaQor, Inc. Cash Flow History

Metric	TTM	Q3 FY2023	Q2 FY2023	Q1 FY2023	Q4 FY2022
Operating Cash Flow	$494.57K	$0.00	$0.00	$-398.51K	$893.08K
Capital Expenditure	$11.58K	$0.00	$0.00	$0.00	$11.58K
Free Cash Flow	$506.14K	$0.00	$0.00	$-398.51K	$904.65K